We are live on ! Find out more
GCM

Ghisallo Capital Management Portfolio holdings

AUM $5.1B
1-Year Est. Return 39.12%
This Fund
S&P 500
This Quarter Est. Return
+1.23%
1 Year Est. Return
+39.12%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.88%
10 Year Est. Return
AUM
$3.63B
AUM Growth
+$1.39B
Cap. Flow
+$1.53B
Cap. Flow %
42.15%
Top 10 Hldgs %
29.82%
Holding
356
New
150
Increased
17
Reduced
25
Closed
81

Top Buys

Rank Stock Value
1
MDLN
Medline Inc
MDLN
+$161M
2
TSLA icon
Tesla
TSLA
+$113M
3
MSFT icon
Microsoft
MSFT
+$105M
4
NVDA icon
NVIDIA
NVDA
+$101M
5
GFS icon
GlobalFoundries
GFS
+$79.4M

Top Sells

Rank Stock Value
1
ITT icon
ITT
ITT
+$78.1M
2
ULS icon
UL Solutions
ULS
+$70.9M
3
SYM icon
Symbotic
SYM
+$46.3M
4
NNE
Nano Nuclear Energy
NNE
+$38.2M
5
KGS icon
Kodiak Gas Services
KGS
+$34M

Sector Composition

Rank Sector Weight
1 Industrials 17.1%
2 Technology 14.38%
3 Consumer Discretionary 11.01%
4 Financials 8.33%
5 Healthcare 6.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MANE
226
Veradermics Inc
MANE
$4.71B
$316K 0.01%
+5,000
New +$252K
NWAX
227
New America Acquisition I Corp
NWAX
$506M
$300K 0.01%
+30,000
New +$302K
AVBH
228
Avidbank Holdings
AVBH
$361M
$285K 0.01%
10,000
FAC
229
Factorial Energy Inc
FAC
$552M
$256K 0.01%
25,000
HCMA
230
HCM III Acquisition Corp
HCMA
$348M
$253K 0.01%
25,000
IMDX
231
Insight Molecular Diagnostics
IMDX
$141M
$232K 0.01%
+70,695
New +$410K
MSAI icon
232
MultiSensor AI
MSAI
$10.5M
$222K 0.01%
24,008
+17,784
+286% +$213K
ZURA icon
233
Zura Bio
ZURA
$534M
$149K ﹤0.01%
+25,000
New +$151K
CRVS icon
234
Corvus Pharmaceuticals
CRVS
$1.25B
$146K ﹤0.01%
+10,000
New +$160K
XLO icon
235
Xilio Therapeutics
XLO
$60.3M
$116K ﹤0.01%
13,800
-65,716
-83% -$538K
TLSI icon
236
TriSalus Life Sciences
TLSI
$324M
$100K ﹤0.01%
+25,000
New +$122K
IEAGR
237
Infinite Eagle Acquisition Corp Rights
IEAGR
$81K ﹤0.01%
+450,000
New +$84.6K
DMIIR
238
Drugs Made In America Acquisition II Corp Right
DMIIR
$60K ﹤0.01%
750,000
CNCK
239
Coincheck Group
CNCK
$391M
$17.4K ﹤0.01%
11,724
-1,043,448
-99% -$2.54M
ACHR icon
240
Archer Aviation
ACHR
$5.1B
-500,000
Closed -$3.76M
AGRO icon
241
Adecoagro
AGRO
$1.29B
-376,666
Closed -$2.99M
ASST icon
242
Strive Inc
ASST
$1.05B
-25,000
Closed -$369K
BABA icon
243
Alibaba
BABA
$297B
-100,000
Closed -$14.7M
CDRE icon
244
Cadre Holdings
CDRE
$1.46B
-103,159
Closed -$4.21M
CEVA icon
245
CEVA Inc
CEVA
$937M
-150,000
Closed -$3.23M
DLO icon
246
dLocal
DLO
$4.17B
-100,000
Closed -$1.41M
GNTA
247
Genenta Science
GNTA
$62.7M
-323,797
Closed -$482K
GROY icon
248
Gold Royalty Corp
GROY
$725M
-850,000
Closed -$3.43M
HYMC icon
249
Hycroft Mining Holding Corp
HYMC
$2.52B
-200,000
Closed -$4.75M
IE icon
250
Ivanhoe Electric
IE
$1.66B
-100,000
Closed -$1.6M

Similar funds

Ghisallo Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Ghisallo Capital Management held 356 positions worth $3.63B, up 62% from $2.24B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Ghisallo Capital Management deployed $1.53B of net new capital in Q1 2026, opening 150 new positions and adding to 17 existing holdings. Its largest new stake was Tesla: 275,000 shares worth $102M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was UL Solutions, an estimated $70.9M trimmed.

  • Ghisallo Capital Management's largest Q1 2026 buy was Tesla: 275,000 shares worth $102M.
  • Ghisallo Capital Management added most to Medline Inc in Q1 2026, an estimated $161M increase.
  • Ghisallo Capital Management's biggest Q1 2026 reduction was UL Solutions, cutting an estimated $70.9M.
  • Ghisallo Capital Management fully exited ITT in Q1 2026, selling an estimated $78.1M.
  • Ghisallo Capital Management's ten largest holdings make up 30% of its $3.63B portfolio in Q1 2026.
  • Ghisallo Capital Management opened 150 new positions and closed 81 in Q1 2026.
  • Ghisallo Capital Management's portfolio value rose 62% quarter-over-quarter to $3.63B.

Based on Ghisallo Capital Management's 13F filing for Q1 2026, filed 15 May 2026.